Edaravone in Digestive Diseases – A Narrative Review

Haiyun Lei,* Mingchun Wang,* Ma Huang,* Xiaoyun Fu Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaoyun F...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei H, Wang M, Huang M, Fu X
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/edaravone-in-digestive-diseases--a-narrative-review-peer-reviewed-fulltext-article-DDDT
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839652126311055360
author Lei H
Wang M
Huang M
Fu X
author_facet Lei H
Wang M
Huang M
Fu X
author_sort Lei H
collection DOAJ
description Haiyun Lei,* Mingchun Wang,* Ma Huang,* Xiaoyun Fu Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaoyun Fu, Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi City, Gui Zhou, People’s Republic of China, Email zyyxyfxy@163.comAbstract: Digestive diseases represent a diverse and complex group of systemic disorders, often marked by intricate pathogenic mechanisms and substantial rates of morbidity, disability, and mortality. While effective therapies exist for certain conditions, such as peptic ulcers, gastrointestinal hemorrhage, and viral hepatitis, many others remain difficult to manage due to their limited treatment options, poor response to current therapies, and multifactorial etiologies. As a result, there is a pressing need to develop novel therapeutic agents that offer greater specificity and improved clinical outcomes. Edaravone, a free radical scavenger widely used in the management of neurological disorders, has demonstrated a favorable safety profile and minimal adverse effects. Recent research has expanded our understanding of Edaravone’s pharmacological actions, revealing its broad therapeutic potential beyond the nervous system. Its capacity to neutralize reactive oxygen species, reduce oxidative stress, suppress inflammation, inhibit apoptosis, modulate immune function, and enhance tissue repair positions it as a promising candidate for treating digestive disorders. This review highlights current advances in the application of Edaravone in digestive disease models and clinical settings, to offer new perspectives for future prevention, therapeutic strategies, and scientific investigation in this field. Keywords: digestive diseases, edaravone, oxidative stress, inflammation, survival
format Article
id doaj-art-c769305b2a4e4aa98d05e5a0b3f8e096
institution Matheson Library
issn 1177-8881
language English
publishDate 2025-06-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj-art-c769305b2a4e4aa98d05e5a0b3f8e0962025-06-25T21:33:44ZengDove Medical PressDrug Design, Development and Therapy1177-88812025-06-01Volume 19Issue 150715084103845Edaravone in Digestive Diseases – A Narrative ReviewLei H0Wang M1Huang M2Fu X3Department of Critical Care MedicineDepartment of Critical Care MedicineDepartment of Critical Care MedicineDepartment of Critical Care MedicineHaiyun Lei,* Mingchun Wang,* Ma Huang,* Xiaoyun Fu Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaoyun Fu, Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi City, Gui Zhou, People’s Republic of China, Email zyyxyfxy@163.comAbstract: Digestive diseases represent a diverse and complex group of systemic disorders, often marked by intricate pathogenic mechanisms and substantial rates of morbidity, disability, and mortality. While effective therapies exist for certain conditions, such as peptic ulcers, gastrointestinal hemorrhage, and viral hepatitis, many others remain difficult to manage due to their limited treatment options, poor response to current therapies, and multifactorial etiologies. As a result, there is a pressing need to develop novel therapeutic agents that offer greater specificity and improved clinical outcomes. Edaravone, a free radical scavenger widely used in the management of neurological disorders, has demonstrated a favorable safety profile and minimal adverse effects. Recent research has expanded our understanding of Edaravone’s pharmacological actions, revealing its broad therapeutic potential beyond the nervous system. Its capacity to neutralize reactive oxygen species, reduce oxidative stress, suppress inflammation, inhibit apoptosis, modulate immune function, and enhance tissue repair positions it as a promising candidate for treating digestive disorders. This review highlights current advances in the application of Edaravone in digestive disease models and clinical settings, to offer new perspectives for future prevention, therapeutic strategies, and scientific investigation in this field. Keywords: digestive diseases, edaravone, oxidative stress, inflammation, survivalhttps://www.dovepress.com/edaravone-in-digestive-diseases--a-narrative-review-peer-reviewed-fulltext-article-DDDTDigestive diseasesEdaravoneoxidative stressinflammationsurvival
spellingShingle Lei H
Wang M
Huang M
Fu X
Edaravone in Digestive Diseases – A Narrative Review
Drug Design, Development and Therapy
Digestive diseases
Edaravone
oxidative stress
inflammation
survival
title Edaravone in Digestive Diseases – A Narrative Review
title_full Edaravone in Digestive Diseases – A Narrative Review
title_fullStr Edaravone in Digestive Diseases – A Narrative Review
title_full_unstemmed Edaravone in Digestive Diseases – A Narrative Review
title_short Edaravone in Digestive Diseases – A Narrative Review
title_sort edaravone in digestive diseases amp ndash a narrative review
topic Digestive diseases
Edaravone
oxidative stress
inflammation
survival
url https://www.dovepress.com/edaravone-in-digestive-diseases--a-narrative-review-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT leih edaravoneindigestivediseasesampndashanarrativereview
AT wangm edaravoneindigestivediseasesampndashanarrativereview
AT huangm edaravoneindigestivediseasesampndashanarrativereview
AT fux edaravoneindigestivediseasesampndashanarrativereview